July 16, 2019 by Chain Drug Review
Cardinal Health, Mike Kaufmann, Steve Mason
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health announced Tuesday that Stephen Mason, president of the company’s Cardinal Health at-Home Solutions business, has been promoted to chief executive officer of Cardinal Health’s Medical segment. Mason will succeed Jon Giacomin, who will be departing the company in mid-August to assume a CEO position at a privately-held company. Mason is
May 30, 2019 by Chain Drug Review
Cardinal Health, future impact of AI on the oncology industry, Joe DePinto, Oncology Insights
Leading Headlines, Pharmacy
DUBLIN, Ohio — Oncologists said they see a growing role for artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research from Cardinal Health Specialty Solutions. These findings were released today in the fifth edition of Oncology Insights, a research-based report series analyzing the views of more than 180
March 20, 2019 by Chain Drug Review
Cardinal Health, Cardinal Health survey of hospital C-suite decision makers, Debbie Weitzman, Mike Brown
Leading Headlines, Pharmacy
DUBLIN, Ohio — More than 50% of hospital executives reported that health care industry pressures, along with the lack of time and resources, prohibit them from focusing on innovative initiatives for the hospital, according to a new Cardinal Health survey of hospital C-suite decision makers. And, more than two-thirds of respondents revealed that they don’t even consider
March 5, 2019 by Chain Drug Review
Cardinal Health, Jeff Williams, Nielsen
Leading Headlines, Pharmacy, Retail News
NEW YORK — Nielsen announced Tuesday that Cardinal Health has selected Nielsen as its primary U.S. analytics provider for retail syndicated market and panel data. Nielsen will be the provider of retail market data for Cardinal Health, supporting its strong network of independent retail pharmacy partners. With this announcement, Nielsen will be adding new retail outlets to
February 7, 2019 by Chain Drug Review
Cardinal Health, Mike Kaufmann
Business, Leading Headlines, Pharmacy, Retail News
DUBLIN, Ohio — Cardinal Health reported on Thursday second quarter fiscal year 2019 revenues of $37.7 billion, an increase of 7%. The company also reported growth in GAAP operating earnings of 26% to $504 million and a decrease in non-GAAP operating earnings of 13 percent to $637 million. GAAP diluted earnings per share (EPS) were $0.93, a decrease of 72
January 23, 2019 by Chain Drug Review
Brian Rice, Cardinal Health, Mike Kaufmann
Leading Headlines, Technology
DUBLIN, Ohio — Cardinal Health announced that Brian Rice will join the company as executive vice president, chief information officer and customer support services. Rice’s most recent role was senior vice president, chief information officer and global business services for Kellogg Company. In his new role at Cardinal Health, he will report to Mike Kaufmann, chief executive officer of Cardinal
January 8, 2019 by Chain Drug Review
B. Douglas Hoey, Cardinal Health, Mirixa Corp., National Community Pharmacists Association (NCPA), Tom Halterman
Leading Headlines, Pharmacy, Retail News, Technology
DUBLIN, Ohio — Cardinal Health announced today it has acquired Mirixa Corp., a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA). The business will integrate into OutcomesMTM, a pioneer in the MTM market, at Cardinal Health. This expanded portfolio from Cardinal Health will bring
December 7, 2018 by Chain Drug Review
Cardinal Health, Gregory Kenny, J. Michael Losh
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee. Losh brings extensive experience serving on the boards of numerous public companies over the past 25 years, including his service as a director of Cardinal
November 30, 2018 by Chain Drug Review
2018 American Society of Hematology Annual Meeting and Exposition, Bruce Feinberg, Cardinal Health, Cardinal Health Specialty Solutions, Chadi Nabhan, Joe DePinto, Medicare Access & CHIP Reauthorization Act (MACRA), Oncology Insights
Leading Headlines, Pharmacy
DUBLIN, Ohio — Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty Solutions. These findings were released today in the fourth edition of Oncology Insights, a research-based report series summarizing the views of more than 160 U.S.
November 28, 2018 by Chain Drug Review
Cardinal Health, inventory management solutions, John Roy, supply chain, WaveMark
Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health inventory management solutions (also known as WaveMark) has introduced a supply chain automation solution designed for the unique challenges hospitals face in operating rooms (OR). The solution is a single health system-wide platform that allows hospitals to streamline their OR processes, reduce costs and improve efficiency through real-time inventory visibility and
November 27, 2018 by Chain Drug Review
2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, Cardinal Health, Cardinal Health Consignment Program, John Kilgour, Kathy Chase
Leading Headlines, Pharmacy
DUBLIN, Ohio — At the upcoming 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting (December 2-6), Cardinal Health will highlight a comprehensive approach that addresses the top concern of hospital and health system pharmacy leaders: sustainable cost control. Attendees can visit the Cardinal Health booth, #1211, to discuss this topic with hospital
November 8, 2018 by Chain Drug Review
Cardinal Health, Mike Kaufmann
Business, Leading Headlines, Pharmacy
DUBLIN, Ohio — Cardinal Health reported first quarter fiscal year 2019 revenues of $35.2 billion, an increase of 8%. The company also reported growth in GAAP operating earnings of 211% to $816 million and a decrease in non-GAAP operating earnings of 11% to $542 million. GAAP operating earnings included a gain of $508 million ($378 million after-tax) related to the naviHealth divestiture.
October 25, 2018 by Chain Drug Review
Cardinal Health, Colleen Lindholz, Kroger, U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day
Leading Headlines, Pharmacy, Retail News
CINCINNATI — Kroger Co. is teaming up with Cardinal Health to host drug take-back events at more than 200 Kroger locations in 13 states. The events will be held from 10 a.m. until 2 p.m. local time on Saturday, October 27. These events are being held in conjunction with the U.S. Drug Enforcement Administration’s National Prescription
October 15, 2018 by Chain Drug Review
Cardinal Health, Mike Kaufmann, Pharmaceutical Segment, Victor Crawford
Leading Headlines, Pharmacy, Retail News
DUBLIN, Ohio — Cardinal Health announced that Victor Crawford will be joining the company as its next chief executive officer of the Pharmaceutical Segment. Victor’s most recent role was CEO, Healthcare, Education and Business Dining for Aramark. In his new role, he will report to Mike Kaufmann, CEO of Cardinal Health. “We are thrilled to welcome Victor to